Working heart function in diabetes is not improved by spironolactone treatment
Authors:
- Violet G YuenVYViolet G Yuen
- Mitesh BadiwalaMBMitesh Badiwala
- Todd J AndersonTATodd J Anderson
- John H McNeillJMJohn H McNeill
- 1 May 2003
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 81 (5) , 493-496
Abstract
Aldosterone antagonism has emerged as an important strategy for end-stage congestive heart failure. To evaluate the potential contribution of aldosterone towards the cardiac complications of diabetes, this study examined the effects of chronic aldosterone receptor blockade (with spironolactone) on isolated working heart function in streptozotocin (STZ) - induced diabetic rats. Wistar rats were divided into four groups: control, control spironolactone-treated, diabetic, and diabetic spironolactone-treated. Following chronic spironolactone treatment (8 weeks), cardiac function was assessed in terms of the rate of contraction (+dP/dT), rate of relaxation (–dP/dT), and left ventricular developed pressure (LVDP). Untreated diabetic rats exhibited marked cardiac dysfunction when compared with age matched controls (p < 0.001). Long-term spironolactone treatment did not improve these parameters. These data demonstrate the lack of beneficial effects of aldosterone receptor blockade on isolated working heart function in diabetes.Key words: aldosterone, streptozotocin-induced diabetes, aldosterone receptor blocker, spironolactone, cardiac function.Keywords
This publication has 17 references indexed in Scilit:
- Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic ratsBritish Journal of Pharmacology, 2001
- Aldosterone inhibition and heart failure: Too good to be true?American Heart Journal, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Risk Factors for Cardiovascular Disease in IDDM: A Study of Identical TwinsDiabetes, 1994
- Hypertriglyceridemia in experimental diabetes: relationship to cardiac dysfunctionCanadian Journal of Physiology and Pharmacology, 1994
- Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertensionThe American Journal of Cardiology, 1993
- Remodeling of the rat right and left ventricles in experimental hypertension.Circulation Research, 1990
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990
- Diabetic cardiomyopathyProgress in Cardiovascular Diseases, 1985
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981